What Hillman Capital Management bought and sold in Q4 2024
In Q4 2024, Hillman Capital Management (Hillman Capital Management) opened 8 new positions — including ASML (3.3%), DEO (2.4%), BF/B (2.1%), added to 7, trimmed 4, exited 6 (SPG, WFC, JWNUSD). The book stood at $270M across 54 positions, filed Feb 14, 2025.
8New7Added4Trimmed6Exited
New positions (8)
Added to (7)
- BABoeing Co/the+20% shares · 3.7% · $10M
- NKENike Inc -cl B+43% shares · 3.2% · $9M
- PFEPfizer Inc+38% shares · 3.1% · $8M
- ELEstee Lauder Companies-cl A+28% shares · 2.9% · $8M
- BIIBBiogen Inc+22% shares · 2.4% · $7M
- SPYSS Spdr S&p 500 Etf Trust-us+180% shares · 1.4% · $4M
- IVVIshares Core S&p 500 Etf+87% shares · 0.2% · $454K
Trimmed (4)
Exited (6)
Hillman Capital Management's other filings
Changes vs the prior quarter's 13F, long US equity positions only (no shorts, options, or non-US listings). ADD/TRIM are share- count changes of ±20% or more. Sourced from SEC EDGAR. Not investment advice.